Showing results (391-400 of 3,164) with videos related to
Sort By:
Pageof 317
Translational Oncology|July 2, 2024
CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinomaDing Ma, Shuwen Liu, Kua Liu, et al.Translational Oncology|July 4, 2024
USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltrationQin Feng, Qian Liu, Zi Liu, et al.Translational Oncology|August 21, 2024
IGFBP1 promotes the proliferation and migration of lung adenocarcinoma cells through the PPARα pathwayYunyun Li, Xuelian Yang, Tao Han, et al.Translational Oncology|August 25, 2024
WDR77 in Pan-Cancer: Revealing expression patterns, genetic insights, and functional roles across diverse tumor types, with a spotlight on colorectal cancerYan Wang, Qihui Wu, Jiaxin Liu, et al.Translational Oncology|August 24, 2024
CircCOCH plays a critical role in Hepatocellular carcinoma through modulating miR-450a and activating PI3K/mTOR pathwayWeiwei Jiang, Yan Wang, Wanli He, et al.Translational Oncology|August 23, 2024
Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomesAhmad Salman Sirajee, Debajyoti Kabiraj, Subhajyoti DeTranslational Oncology|August 23, 2024
Multifaceted role of GCN2 in tumor adaptation and therapeutic targetingCan Chen, Yaping Xie, Shenxian QianTranslational Oncology|August 22, 2024
GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancerJunjie Nie, Xinwei Liu, Mu Xu, et al.Translational Oncology|August 27, 2024
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivoNeil T Conlon, Sandra Roche, Amira F Mahdi, et al.Translational Oncology|May 26, 2024
Non-coding RNA in exosomes: Regulating bone metastasis of lung cancer and its clinical application prospectQing Yang, Wei Wang, Dezhou Cheng, et al.Pageof 317